{
    "clinical_study": {
        "@rank": "97301", 
        "arm_group": {
            "arm_group_label": "Liver disease and liver transplantation", 
            "description": "Patient with end stage liver disease and/or primary liver tumor undergoing liver transplantation"
        }, 
        "brief_summary": {
            "textblock": "Recent experimental and clinical studies have shown that platelets play a critical role in\n      liver ischemia and regeneration. Thrombocytopenia, a frequent and potentially serious\n      condition in liver transplantation (LT) recipients, was shown to be associated with\n      postoperative morbidity and mortality after partial hepatectomy.\n\n      The investigators aim at evaluating whether postoperative low platelet counts are indicators\n      of short- and long-term outcomes after liver transplantation."
        }, 
        "brief_title": "The Perioperative Value of Platelet Counts in Predicting Outcome After Liver Transplantation", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Complication", 
            "Death"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age >18 years old\n\n          -  End stage liver disease\n\n          -  Cadaveric-donor liver transplantation\n\n        Exclusion Criteria:\n\n          -  Age <18 years old\n\n          -  Pregnancy\n\n          -  Living-related liver transplantation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with end stage liver disease and/or primary liver tumor undergoing liver\n        transplantation"
            }
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 18, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01711957", 
            "org_study_id": "EK-1487"
        }, 
        "intervention": {
            "arm_group_label": "Liver disease and liver transplantation", 
            "description": "Standardized technique of liver transplantation Organ procurement follow the rules of the Swiss transplant society", 
            "intervention_name": "Liver transplantation", 
            "intervention_type": "Procedure", 
            "other_name": [
                "Orthotopic liver transplantation (OLT)", 
                "Cadaveric-donor liver transplantation"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Liver Extracts"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Complications", 
            "Mortality", 
            "Liver transplantation", 
            "Platelet count", 
            "Survival"
        ], 
        "lastchanged_date": "October 23, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Zurich", 
                    "country": "Switzerland", 
                    "zip": "8091"
                }, 
                "name": "University Hospital Zurich, Department of Visceral Surgery and Transplantation"
            }
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_groups": "1", 
        "official_title": "The Perioperative Value of Platelet Counts in Predicting Outcome After Liver Transplantation", 
        "other_outcome": {
            "measure": "Patient survival", 
            "safety_issue": "No", 
            "time_frame": "3-year"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Zurich", 
                "last_name": "Mickael Lesurtel, M.D., PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "University of Zurich", 
                "last_name": "Pierre-Alain Clavien, M.D., PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "University of Zurich", 
                "last_name": "Dimitri A. Raptis, M.D., MSc", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Zurich", 
                "last_name": "Emmanuel Melloul, M.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Switzerland: Federal Office of Public Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The severity of complications will be graded according to the Clavien-Dindo classification by outcome. Grade III to V complications will be considered as severe.", 
            "measure": "Severe complication after liver transplantation", 
            "safety_issue": "No", 
            "time_frame": "90 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01711957"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Zurich", 
            "investigator_full_name": "Dimitri Aristotle Raptis", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Defined as death or retransplantation within the first postoperative week after exclusion of technical, immunological, and infectious causes", 
                "measure": "Primary graft non-function", 
                "safety_issue": "No", 
                "time_frame": "first postoperative week"
            }, 
            {
                "description": "Defined as the presence of at least one of the following parameter at 7 days after LT: serum bilirubin > 10 mg/dL and International Normalized Ratio (INR) >1.6 or Alanine aminotransferase serum level (ALT) >2000UI/L", 
                "measure": "Delayed graft function", 
                "safety_issue": "No", 
                "time_frame": "7 days after liver transplantation"
            }
        ], 
        "source": "University of Zurich", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Zurich", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2008", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2012"
    }
}